PHARMACOKINETIC STUDY OF ZIMELIDINE USING A NEW GLC METHOD

被引:4
作者
CAILLE, G [1 ]
KOUASSI, E [1 ]
DEMONTIGNY, C [1 ]
机构
[1] UNIV MONTREAL, FAC MED, NEUROSCI RES CTR, MONTREAL H3C 3J7, QUEBEC, CANADA
关键词
D O I
10.2165/00003088-198308060-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:530 / 540
页数:11
相关论文
共 36 条
[1]   PRELIMINARY CLINICAL TEST OF ZIMELIDINE (H 102-09), A NEW 5-HT UPTAKE INHIBITOR [J].
ABERG, A ;
HOLMBERG, G .
ACTA PSYCHIATRICA SCANDINAVICA, 1979, 59 (01) :45-58
[3]   EFFECTS OF ZIMELIDINE AND DESIPRAMINE ON SEROTONIN AND NORADRENALINE UPTAKE MECHANISMS IN RELATION TO PLASMA-CONCENTRATIONS AND TO THERAPEUTIC EFFECTS DURING TREATMENT OF DEPRESSION [J].
ABERGWISTEDT, A ;
JOSTELL, KG ;
ROSS, SB ;
WESTERLUND, D .
PSYCHOPHARMACOLOGY, 1981, 74 (04) :297-305
[4]   INDIVIDUAL DIFFERENCES IN PHARMACOKINETICS OF MONOMETHYLATED TRICYCLIC ANTIDEPRESSANTS - ROLE OF GENETIC AND ENVIRONMENTAL FACTORS AND CLINICAL IMPORTANCE [J].
ALEXANDERSON, B ;
SJOQVIST, F .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :739-+
[5]   STEADY-STATE PLASMA LEVELS OF NORTRIPTYLINE INTWINS - INFLUENCE OF GENETIC FACTORS AND DRUG THERAPY [J].
ALEXANDERSON, B ;
EVANS, DAP ;
SJOQVIST, F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 4 (5686) :764-+
[6]   RELATIONSHIP BETWEEN PLASMA LEVEL AND THERAPEUTIC EFFECT OF NORTRIPTYLINE [J].
ASBERG, M ;
CRONHOLM, B ;
SJOQVIST, F ;
TUCK, D .
BRITISH MEDICAL JOURNAL, 1971, 3 (5770) :331-&
[7]   BIOCHEMICAL EFFECTS OF ZIMELIDINE IN MAN [J].
BERTILSSON, L ;
TUCK, JR ;
SIWERS, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (06) :483-487
[8]  
BORG KO, 1979, ACTA PHARMACOL TOX, V45, P198
[9]   PHARMACOKINETICS OF ZIMELIDINE - SYSTEMIC AVAILABILITY OF ZIMELIDINE AND NORZIMELIDINE IN HUMAN VOLUNTEERS [J].
BROWN, D ;
SCOTT, DHT ;
SCOTT, DB ;
MEYER, M ;
WESTERLUND, D ;
LUNDSTROM, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :111-116
[10]   ZIMELIDINE AND NORZIMELIDINE PROTEIN-BINDING MEASURED BY EQUILIBRIUM DIALYSIS AND CEREBROSPINAL-FLUID [J].
CALIL, HM ;
JOSTELL, KG ;
COWDRY, RW ;
POTTER, WZ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :522-527